RASGRP1 and Dyskinesia: Moreover, as previously explained, simultaneous signaling by the RasGRP1/Rheb/mTORC1 and RasGRP1/H-Ras/ERK axes could underlie the dyskinesia suffered by PD patients who have been treated with L-DOPA for a prolonged time [29].